(ASHR) Xtrackers Harvest CSI 300 - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US2330518794
ASHR: China A-Shares, Small-Cap Stocks, Mid-Cap Stocks, Large-Cap Stocks, ETF
The Xtrackers Harvest CSI300 China A-Shares ETF (NYSE ARCA:ASHR) is an exchange-traded fund that tracks the CSI 300 Index, providing investors with exposure to the Chinese A-share market. By investing at least 80% of its assets in the securities that comprise the underlying index, the fund offers a diversified portfolio of 300 of the largest and most liquid Chinese stocks, spanning small-cap, mid-cap, and large-cap segments.
The CSI 300 Index is a widely recognized benchmark for the Chinese A-share market, reflecting the overall performance and price fluctuations of the market. As the fund is non-diversified, it is heavily reliant on the performance of the underlying index, making it essential for investors to closely monitor the indexs constituents and overall market trends.
From a technical analysis perspective, the current price of ASHR is $27.02, indicating a potential buying opportunity as it is above its 20-day and 50-day simple moving averages (SMA20: $26.81, SMA50: $26.23). However, the funds price is below its 52-week high of $35.05, suggesting a significant correction. The average true range (ATR) of 0.25, equivalent to 0.93%, indicates moderate volatility.
Considering the funds assets under management (AUM) of $2000.61M USD, it is evident that ASHR has a substantial presence in the market. Given the current technical and fundamental data, a forecast for ASHR could be that it will continue to consolidate around its current price levels, potentially breaking out above its SMA20 or SMA50 in the short term. However, a sustained rally above $28.00 could signal a stronger upward trend, while a drop below $26.00 may indicate a further decline.
To make an informed investment decision, it is crucial to closely monitor the CSI 300 Index, Chinese economic indicators, and overall market sentiment. A thorough analysis of these factors will enable investors to better understand the potential risks and opportunities associated with ASHR, ultimately making a more informed decision.
Additional Sources for ASHR ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
ASHR ETF Overview
Market Cap in USD | 2,001m |
Category | China Region |
TER | 0.65% |
IPO / Inception | 2013-11-06 |
ASHR ETF Ratings
Growth Rating | -14.6 |
Fundamental | - |
Dividend Rating | 18.3 |
Rel. Strength | 1 |
Analysts | - |
Fair Price Momentum | 24.90 USD |
Fair Price DCF | - |
ASHR Dividends
Dividend Yield 12m | 1.13% |
Yield on Cost 5y | 1.13% |
Annual Growth 5y | -1.65% |
Payout Consistency | 78.1% |
Payout Ratio | % |
ASHR Growth Ratios
Growth Correlation 3m | 23.3% |
Growth Correlation 12m | 43.8% |
Growth Correlation 5y | -78.4% |
CAGR 5y | 0.18% |
CAGR/Max DD 5y | 0.00 |
Sharpe Ratio 12m | -0.45 |
Alpha | 5.79 |
Beta | 0.355 |
Volatility | 18.21% |
Current Volume | 5260.1k |
Average Volume 20d | 5181.9k |
As of June 15, 2025, the stock is trading at USD 26.75 with a total of 5,260,149 shares traded.
Over the past week, the price has changed by -0.34%, over one month by -0.89%, over three months by -0.67% and over the past year by +12.57%.
Neither. Based on ValueRay´s Analyses, Xtrackers Harvest CSI 300 is currently (June 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of -14.64 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ASHR is around 24.90 USD . This means that ASHR is currently overvalued and has a potential downside of -6.92%.
Xtrackers Harvest CSI 300 has no consensus analysts rating.
According to our own proprietary Forecast Model, ASHR Xtrackers Harvest CSI 300 will be worth about 27.3 in June 2026. The stock is currently trading at 26.75. This means that the stock has a potential upside of +2.09%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 27.3 | 2.1% |